Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Delving into the data from the SLEek clinical trial on Abbvie's RINVOQ (upadacitinib) in treating patients with Systemic Lupus Erythematosus.

Ticker(s): ABBV

Who's the expert?

Institution: University of Pittsburgh Medical Center

Assistant Professor of Medicine and Staff Rheumatologist-University of Pittsburgh Medical Center.
Manages 180 patients with rheumatoid arthritis, 50 patients with Systemic Lupus Erythematosus
Research interests include inflammatory myopathies and biomarker clinical studies.

Interview Goal

To discuss the standard of care for managing SLE and the potential label expansion of Abbvie's RINVOQ (upadacitinib) in treating patients with SLE. The call will primarily focus on the recent phase 2 SLEek clinical trial of RINVOQ (upadacitinib) in patients with SLE.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.